Weston Brain Institute Rapid Response 2018 - Parkinson's & Related Diseases

The Weston Brain Institute (the “Institute”) supports research that accelerates the development of therapeutics for neurodegenerative diseases of aging. To help achieve this, the Institute addresses gaps and inefficiencies in the funding market by supporting high-risk, high-reward translational projects, while leveraging world-class business and scientific expertise in a fast and flexible granting process.

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. Diseases such as Alzheimer’s and Parkinson’s are placing a large and increasing burden on society. If ignored, the social and economic costs to manage these diseases will rise significantly within a generation.

Meeting this challenge requires pioneering approaches to accelerating treatments. The Canada: Rapid Response program was created to provide seed funding for novel, high-risk, high-reward, translational research to accelerate the development of safe and effective treatments for neurodegenerative diseases of aging.

Disease Groups

This program is run through alternating calls that are disease focused:

  • Parkinson’s & Related Diseases: PD, PSP, LBD, MSA,  prodromes, and vascular contributions to the listed diseases. Launch: Currently open  
  • Alzheimer’s & Related Diseases: AD, FTD, MCI  prodromes, and vascular contributions to the listed diseases. Launch: November 2017
Key Dates
  • Program Information Session: October 10, 2017 at 1pm EDT (Register here)
  • Letter of Intent Deadline: December 4, 2017 at 2pm EST 
  • Anticipated Award: June 2018

The Weston Brain Institute welcomes any inquiries concerning this program announcement. Please contact the Institute at neuro@weston.ca or +1 (416) 935-4056.


Application Procedures

There are two stages to the application process: Letters of Intent and Proposals. An application requires the submission of a Letter of Intent which will be reviewed by our scientific review committee. Applicants with high potential projects will then be invited to submit a Proposal. Instructions for submitting the Proposal will be forwarded to those invited in July 2017.

Please view http://westonbraininstitute.ca/rapid-response-canada-2018/ for detailed application instructions and forms.

Eligibility Summary

Applicant Eligibility: 

Eligible Principal Applicants must be researchers working in Canada at least 30% of the time at or above the level of Postdoctoral Fellow, and be affiliated with a Canada Revenue Agency-qualified donee institution located in Canada.

If the Principal Applicant is not appointed at the institution from which they are applying, they need to apply with a research supervisor (an “Administrative Supervisor”) who is at or above the level of Assistant Professor or equivalent, with an appointment at the institution from which they are applying.

Applicants may appear in any role on any number of projects.

Project Eligibility: 

Projects must meet two conditions to be eligible:

  • Be translational research that helps accelerate the development of therapeutics for neurodegenerative diseases of aging
  • Be the development of a therapeutic and/or tool

Annual Value

$ 200,000